RecallDepth
Class II Terminated

RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b) 12-count (2 cards x 6 tablets) per carton, NDC 0049-2340-05, Rx only, Made in Ireland, Distributed by Pfizer Roerig, Division of Pfizer Inc., NY, NY 10017.

This recall has been terminated (originally issued September 4, 2019).

Company
Pfizer Inc.
Recall Initiated
August 14, 2019
Posted
September 4, 2019
Recall Number
D-1845-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 20,117 cartons; b) 2,502 cartons
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.

Distribution

Nationwide in the USA and Puerto Rico.

Lot / Code Info

Lot #: a) AR5407, Exp 2022 FEB; b) CD4565, Exp 2022 FEB

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls